Cardiometabolic risk in patients with polycystic ovary syndrome.
Open accessAbstract
OBJECTIVES: Polycystic ovary syndrome (PCOS) is a common endocrinopathy in premenopausal women, associated with risk of metabolic syndrome and cardiovascular disease (CVD). CVD risk evaluation is recommended for PCOS patients. This study aimed to evaluate the risk of CVD in PCOS patients and to identify the best predictors for metabolic and cardiovascular disturbances. MATERIAL AND METHODS: The study included 169 PCOS patients and 110 healthy women in reproductive age. We estimated cardiovascular risk according to American Heart Association and Androgen Excess-PCOS Society criteria that classified patients as metabolically unhealthy (MU) or metabolically healthy (MH). RESULTS: The PCOS group had significantly higher body mass index (BMI), waist circumference, and waist-to-hip ratio (P < 0.000001). Metabolic syndrome was only defined among PCOS patients (8.9%). No obesity was observed in the control group. Waist circumference ≥ 80 cm was presented in 44% of PCOS patients in comparison to 14.5% of control participants (P < 0.000001). There was a significant tendency for higher fasting insulin levels in the PCOS population (P < 0.00001). Surprisingly the PCOS-MH group had the highest high-density lipoprotein (HDL) levels. ROC curves were used to indicate parameters diagnosing metabolically unhealthy women and revealed that WC, BMI and HC seem to be the strongest predictors of metabolic disturbances in PCOS but in the healthy population in reproductive age biochemical findings such as low HDL or increased fasting glycemia presented stronger predictive value than patients' anthropometric features. CONCLUSIONS: Physicians need to remember to adopt different diagnostic approach while seeking metabolic complications in these different groups of women.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Metabolic derangements linked to the risk of cardiovascular disease, including weight gain, decreased insulin sensitivity, dyslipidaemia, and hypertension, are prevalent in women with risk factors for cardiovascular disease specific to women.
“Metabolic derangements linked to the risk of cardiovascular disease, including weight gain, decreased insulin sensitivity, dyslipidaemia, and hypertension, are prevalent in women with risk factors for cardiovascular disease specific to women”
From Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review (2020) · cites this paper as [141]
Cites
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961 · see citing works
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,761 · see citing works
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · see citing works
Waist circumference and not body mass index explains obesity-related health risk
Janssen, I., Katzmarzyk, P. T., & Ross, R. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.3.379 · Cited by 2,009 · see citing works
Amato, M. C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., Galluzzo, A., & for the AlkaMeSy Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1825 · Cited by 1,751 · see citing works
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488 · see citing works
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108 · cited 1× · see citing works
“K ;O< ; < ; < 59 (53,6) ; < ST B S' C B S' C B S'”
Diamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6148 · Cited by 1,107 · see citing works
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s055 · Cited by 1,062 · cited 1× · see citing works
“< ; < 42 (25) -2 % "! ;G < ; < 74 ( 44) *) ; < ; < * +,- ,- /.”
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010 · see citing works
Wild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970 · see citing works
Lim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms030 · Cited by 939 · see citing works
Obesity and the polycystic ovary syndrome
Gambineri, A., Pelusi, C., Vicennati, V., Pagotto, U., & Pasquali, R. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801994 · Cited by 838 · see citing works
Stepto, N. K., Cassar, S., Joham, A. E., Hutchison, S. K., Harrison, C. L., Goldstein, R. F., & Teede, H. J. (2013) · Human Reproduction · doi:10.1093/humrep/des463 · Cited by 747 · see citing works
Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Ehrmann, D. A., Liljenquist, D. R., Kasza, K., Azziz, R., Legro, R. S., & Ghazzi, M. N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1329 · Cited by 703 · see citing works
Glueck, C. J., Papanna, R., Wang, P., Goldenberg, N., & Sieve-Smith, L. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00104-5 · Cited by 396 · see citing works
de Groot, P. C. M., Dekkers, O. M., Romijn, J. A., Dieben, S. W. M., & Helmerhorst, F. M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr001 · Cited by 394 · see citing works
Consensus on women's health aspects of polycystic ovary syndrome (PCOS)
The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group, Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R. A., Carmina, H., Chang, R. J., Yıldız, B. O., et al. (2011) · Human Reproduction · doi:10.1093/humrep/der396 · Cited by 368 · see citing works
Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome
Dokras, A., Bochner, M., Hollinrake, E., Markham, S. M., Voorhis, B. J. V., & Jagasia, D. H. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000167408.30893.6b · Cited by 353 · see citing works
Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease
Dagenais, G. R., Yi, Q., Mann, J. F. E., Bosch, J., Pogue, J., & Yusuf, S. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.07.009 · Cited by 343 · see citing works
Metabolically healthy obesity: different prevalences using different criteria
Velho, S., Paccaud, F. M., Waeber, G., Vollenweider, P., & Marques-Vidal, P. M. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.114 · Cited by 247 · see citing works
Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria
Juran, R., Syrop, C. H., Davis, W. A., Voorhis, B. J. V., & Dokras, A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.01.032 · Cited by 214 · see citing works
Carmina, E., Napoli, N., Longo, R. A., Rini, G. B., & Lobo, R. A. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02058 · Cited by 202 · see citing works
Insulin resistance in polycystic ovary syndrome: progress and paradoxes.
Venkatesan, A. M., Dunaif, A., & Corbould, A. (2001) · Recent Progress in Hormone Research · doi:10.1210/rp.56.1.295 · Cited by 175 · see citing works
Cussons, A. J., Watts, G. F., Burke, V., Shaw, J. E., Zimmet, P. Z., & Stuckey, B. G. A. (2008) · Human Reproduction · doi:10.1093/humrep/den263 · Cited by 140 · see citing works
Goverde, A. J., van Koert, A. J. B., Eijkemans, M. J., Knauff, E. A. H., Westerveld, H. E., Fauser, B. C. J. M., & Broekmans, F. J. (2008) · Human Reproduction · doi:10.1093/humrep/den433 · Cited by 135 · see citing works
Metabolic impact of body fat distribution
Gasteyger, C., & Tremblay, A. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344051 · Cited by 95 · see citing works
Prevalence of the Metabolic Syndrome in German Women with Polycystic Ovary Syndrome
Hahn, S., Tan, S., Sack, S., Kimmig, R., Quadbeck, B., Mann, K., & Janssen, O. E. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-967093 · Cited by 80 · see citing works
Prevalence of metabolic syndrome in women with polycystic ovary syndrome
Panidis, D., Μacut, D., Τζιόμαλος, Κ., Papadakis, E. P., Mikhailidis, K., Kandaraki, E., Tsourdi, E. A., Tantanasis, T., Mavromatidis, G., & Katsikis, I. (2012) · Clinical Endocrinology · doi:10.1111/cen.12008 · Cited by 79 · see citing works
Metabolic syndrome and polycystic ovary syndrome... and vice versa
Kandaraki, E., Christakou, C. D., & Diamanti‐Kandarakis, E. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200014 · Cited by 67 · see citing works
Weerakiet, S., Bunnag, P., Phakdeekitcharoen, B., Wansumrith, S., Chanprasertyothin, S., Jultanmas, R., & Thakkinstian, A. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701214158 · Cited by 59 · see citing works
Amato, M. C., Guarnotta, V., Forti, D., Donatelli, M., Dolcimascolo, S., & Giordano, C. S. D. S. (2013) · Human Reproduction · doi:10.1093/humrep/det105 · Cited by 38 · see citing works
Guidelines for prevention of cardiovascular disease in women: a summary of recommendations.
Mosca, L. (2007) · Preventive Cardiology · doi:10.1111/j.1520-037x.2007.07255.x · Cited by 30 · see citing works
Flagged first, then by citations
6 of the 39 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Okoth, K., Chandan, J. S., Marshall, T., Thangaratinam, S., Thomas, G. N., Nirantharakumar, K., & Adderley, N. J. (2020) · BMJ · doi:10.1136/bmj.m3502 · Cited by 416 · see citing works
Kakoly, N. S., Khomami, M. B., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., Ranasinha, S., Teede, H. J., & Moran, L. J. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy007 · Cited by 384 · see citing works
Lim, S. S., Kakoly, N. S., Tan, J. W. J., Fitzgerald, G., Bahri Khomami, M., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., et al. (2019) · Obesity Reviews · doi:10.1111/obr.12762 · Cited by 316 · see citing works
“Six studies were conducted in adolescents (6, 41, 56, 59-61) (Table 2).”
BackgroundPolycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis.
Zhao, L., Zhu, Z., Lou, H., Zhu, G., Huang, W., Zhang, S., & Liu, F. (2016) · Oncotarget · doi:10.18632/oncotarget.9553 · Cited by 174 · see citing works
“indicated that PCOS patients had higher CVD risk factors, such as body mass index (BMI), waist circumference, and waist-to-hip ratio [20].”
BackgroundZhou, Y., Wang, X., Jiang, Y., Ma, H., Chen, L., Lai, C., Peng, C., He, C., & Sun, C. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1347779 · Cited by 64 · see citing works
Coronary artery disease risk in young women with polycystic ovary syndrome
Ding, D., Tsai, I., Wang, J., Lin, S., & Sung, F. (2018) · Oncotarget · doi:10.18632/oncotarget.23985 · Cited by 61 · see citing works
Lewandowski, K. C., Skowrońska‐Jóźwiak, E., Łukasiak, K., Gałuszko, K., Dukowicz, A., Cedro, M., & Lewiñski, A. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.82672 · Cited by 55 · see citing works
Serum Metabolomics in PCOS Women with Different Body Mass Index
Ożegowska, K., Plewa, S., Mantaj, U., Pawelczyk, L. A., & Matysiak, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132811 · Cited by 23 · see citing works
Self-citationOżegowska, K., Korman, M., Szmyt, A., & Pawelczyk, L. A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17249291 · Cited by 18 · see citing works
Self-citationCalzada, M. J., López, N., Velasco, J. A. N., Mendiola, J., & Torres-Cantero, A. M. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0888-y · Cited by 10 · see citing works
Huang, N., Li, N., Zhuang, Z., Song, Z., Wang, W., Dong, X. Y., Xiao, W., Li, Y., Zhao, Y., & Huang, T. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117553 · Cited by 5 · see citing works
Polycystic Ovary Syndrome and Cardiometabolic Disease
Wang, S., Navratil, A. M., & Ren, J. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-805253-2.00013-4
Huang, T., Huang, N., Li, N., Zhuang, Z., Song, Z., Wang, W., Xue, D. Q., Xiao, W., Li, Y., & Zhao, Y. (2023) · doi:10.22541/au.167852168.88711802/v1
Radanović, D., Matić, S., Pajic, S. S., Slijepčević, N., Knežević, S., Jakovljević, S., Elboursh, D., Mirčić, U., Čukić, B., & Savić, A. (2023) · Research Square · doi:10.21203/rs.3.rs-3047102/v1
Ulloque‐Badaracco, J. R., Hernández-Bustamante, E. A., Cabrera-Guzmán, J. C., Delgado-Raygada, J. E., Dotto-Vasquez, G., Maldonado-Basurto, G. F., Figueroa-Larragán, A. A., Trujillo-Jurado, K. Z., Ballmann, G. E., Flores-Gavino, A., et al. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251397203
- Authors
- Ozegowska, K., & Pawelczyk, L.
- ORCID
- Pawelczyk, Leszek
- Venue
- Polish Gynaecology
- Publisher
- VM Media Group sp. z o.o
- Published
- 2015
- Volume
- 86
- Issue
- 11
- Pages
- 840-8
- ISSN
- 0017-0011 (ISSN-L)
- OpenAlex
- W2426142355
- Cited by
- 15
- References
- 39
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 2 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 5 · 2017: 1 · 2016: 1
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Ginekologia Polska (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, cardiometabolic risk, cardiovascular risk, metabolic syndrome, waist circumference, body mass index, waist-to-hip ratio, fasting insulin, HDL cholesterol, fasting blood glucose, obesity, cardiovascular risk prediction
- MeSH terms
- Adult, Cardiovascular Diseases, Cholesterol, Female, Humans, Obesity, Poland, Polycystic Ovary Syndrome, Risk Factors, Body Mass Index, Women's Health, Metabolic Syndrome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
